Illumina, Inc. (ILMN)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for ILMN is $218.92, 16.6% below the last close of $262.54 on Oct 16, 2026; targets range from $136.43 to $307.15. Rating consensus: Hold.
Snapshot
- P/E49.0x
- P/E vs sector+74.0%
- P/E vs own+96.8%
- Target upside-16.6%
- ConsensusHold
- Market cap$39.64B
- FCF yield+2.4%
- Insiders-$436M
- Earnings in13d
- News
Why it moved
Illumina, Inc. (ILMN) fell 2.0% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move is specific to ILMN.
2 stories on the day (30-day average 0.6).
- First Citizens Bank & Trust Co. Purchases New Shares in Illumina, Inc. $ILMN
- Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report?
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $262.54 · +173.7% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendbullish
- Sector▲ +16.0%
- MAs20▼ 50▲ 100▲ 200▲
- Above MAs3 of 4 above
- MA20×50—
- RSI53
- Support-22.6%
- Resistance—
- Off 52w high-10.6%
- Off ATH-48.5%
- 52w range$262.54
- Bollingerlower half
- MACD-3.02
- ATR+5.1%
- Volume0.9x
Analyst price targets
13 firms with a target in the last 12 months · last close $262.54 · as of Oct 16, 2026
Strong buy 4 · Buy 7 · Hold 6 · Sell 2 · Strong sell 2
Revenue and free cash flow
Q2 FY2026: Revenue +9.6% year over year, free cash flow 13.9% of revenue, operating margin 21.1%.
| Q2 FY2026 | Jun 28, 2026 | $1.16B | 1.35 | $161M | 66.4% | 21.1% | 17.9% |
| Q1 FY2026 | Mar 29, 2026 | $1.09B | 0.87 | $251M | 66.1% | 19.2% | 12.3% |
| Q4 FY2025 | Dec 28, 2025 | $1.16B | 2.17 | $267M | 67.1% | 22.2% | 28.8% |
| Q3 FY2025 | Sep 28, 2025 | $1.08B | 0.97 | $260M | 67.6% | 21.3% | 13.9% |
| Q2 FY2025 | Jun 29, 2025 | $1.06B | 1.50 | $211M | 67.8% | 21.0% | 22.2% |
| Q1 FY2025 | Mar 30, 2025 | $1.04B | 0.82 | $201M | 65.8% | 17.7% | 12.6% |
| Q4 FY2024 | Dec 29, 2024 | $1.1B | 1.17 | $335M | 65.9% | 18.3% | 16.9% |
| Q3 FY2024 | Sep 29, 2024 | $1.08B | 4.41 | $284M | 69.0% | 68.6% | 65.3% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $172.97 | -1.5% | -1.5% | +0.5% | 34.0 | $48.77B | |
| 2 |  | $560.36 | +2.4% | -26.9% | +34.9% | 39.7 | $44.15B | |
| 3 |  | $266.90 | -1.5% | -3.0% | +3.6% | 33.1 | $43.93B | |
| 4 |  | $436.95 | -1.6% | -1.6% | +4.4% | 109.0 | $42.9B | |
| 5 | | $262.54 | -2.0% | -10.6% | -16.6% | 49.0 | $39.64B | |
| 6 |  | $1,622.29 | -1.0% | -1.0% | -7.3% | 36.5 | $32.51B | |
| 7 |  | $235.00 | -1.7% | -4.7% | -0.5% | 24.9 | $25.94B | |
| 8 |  | $317.95 | -2.2% | -6.1% | +5.8% | 26.3 | $25.79B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.